Buy or sell Glooko stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Glooko Stock
Unified platform for Diabetes management
About Glooko Stock
Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.
Investors
Canaan Partners
Instacart, Snyk, Turo, Dragos, The RealReal, MindTickle, Lending Club, Berkshire Grey, Apartment List, Tomorrow.io
Georgian Partners
Welltok, Armis Security, Tealium, WorkFusion, DISCO, True Fit, Ritual, Reonomy, Signpost, FreshBooks
Insulet
Medtronic
Social Capital
Slack, Relativity Space, Netskope, Box, BetterUp, Greenlight, Guild Education, Flutterwave, Palmetto Clean Technology, Groq
Funding History
November 2010 | $1.0M |
---|---|
January 2012 | $3.5M |
January 2014 | $7.0M |
March 2015 | $16.5M |
September 2016 | $8.0M |
June 2017 | $35.0M |
Management
Chief Executive Officer
Russ Johannesson
Co-Founder
Yogen Dalal
Chief Medical Officer
Michael S. Greenfield
Chief Commercial Officer
David Conn
Press
prnewswire - Sep, 17 2019
prnewswire - Jul, 23 2019
prnewswire - Jun, 5 2019
prnewswire - Jun, 4 2019
benzinga - Apr, 25 2019
mobihealthnews - Mar, 5 2019
fiercebiotech - Mar, 5 2019
mobihealthnews - Feb, 18 2019
businesswire - Jul, 12 2018
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase